Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Raynor

Showing results (41-50 of 121) with videos related to

Pageof 13
Sort By:
The International Journal of Pharmacy Practice|November 9, 2010
Developing and testing a patient information booklet for thrombolysis used in acute strokePeter Knapp, Peter Wanklyn, D K Raynor, et al.
Journal of Medical Ethics|September 1, 2009
Performance-based readability testing of participant materials for a phase I trial: TGN1412P Knapp, D K Raynor, J Silcock, et al.
Therapeutic Innovation & Regulatory Science|September 21, 2018
Do Patients Use a Headline Section in a Leaflet to Find Key Information About Their Medicines? Findings From a User-Test StudyRebecca Dickinson, David K Raynor, Peter Knapp, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 15, 1991
Desmocollins form a distinct subset of the cadherin family of cell adhesion moleculesS Mechanic, K Raynor, J E Hill, et al.
BMC Medicine|July 23, 2011
Can user testing of a clinical trial patient information sheet make it fit-for-purpose?--a randomized controlled trialPeter Knapp, David K Raynor, Jonathan Silcock, et al.
Contraception|November 22, 2002
Official warnings on thromboembolism risk with oral contraceptives fail to inform users adequatelyDianne C Berry, D K Raynor, Peter Knapp, et al.
Molecular Pharmacology|August 1, 1994
Characterization of cloned human somatostatin receptor SSTR5A M O'Carroll, K Raynor, S J Lolait, et al.
Patient Preference and Adherence|July 18, 2015
Consumer interpretation of ramipril and clopidogrel medication risk information - implications for risk communication strategiesVivien Tong, David K Raynor, Susan J Blalock, et al.
Health & Social Care in the Community|May 10, 2017
Exploring the prevalence of and factors associated with advice on prescription medicines: A survey of community pharmacies in an English cityPeter H Rivers, Jon Waterfield, Martin Grootveld, et al.
Drug Safety|December 24, 2002
Patients' understanding of risk associated with medication use: impact of European Commission guidelines and other risk scalesDianne C Berry, D K Raynor, Peter Knapp, et al.
Pageof 13

Showing results (41-50 of 121) with videos related to

Sort By:
Pageof 13
The International Journal of Pharmacy Practice|November 9, 2010
Developing and testing a patient information booklet for thrombolysis used in acute strokePeter Knapp, Peter Wanklyn, D K Raynor, et al.
Journal of Medical Ethics|September 1, 2009
Performance-based readability testing of participant materials for a phase I trial: TGN1412P Knapp, D K Raynor, J Silcock, et al.
Therapeutic Innovation & Regulatory Science|September 21, 2018
Do Patients Use a Headline Section in a Leaflet to Find Key Information About Their Medicines? Findings From a User-Test StudyRebecca Dickinson, David K Raynor, Peter Knapp, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 15, 1991
Desmocollins form a distinct subset of the cadherin family of cell adhesion moleculesS Mechanic, K Raynor, J E Hill, et al.
BMC Medicine|July 23, 2011
Can user testing of a clinical trial patient information sheet make it fit-for-purpose?--a randomized controlled trialPeter Knapp, David K Raynor, Jonathan Silcock, et al.
Contraception|November 22, 2002
Official warnings on thromboembolism risk with oral contraceptives fail to inform users adequatelyDianne C Berry, D K Raynor, Peter Knapp, et al.
Molecular Pharmacology|August 1, 1994
Characterization of cloned human somatostatin receptor SSTR5A M O'Carroll, K Raynor, S J Lolait, et al.
Patient Preference and Adherence|July 18, 2015
Consumer interpretation of ramipril and clopidogrel medication risk information - implications for risk communication strategiesVivien Tong, David K Raynor, Susan J Blalock, et al.
Health & Social Care in the Community|May 10, 2017
Exploring the prevalence of and factors associated with advice on prescription medicines: A survey of community pharmacies in an English cityPeter H Rivers, Jon Waterfield, Martin Grootveld, et al.
Drug Safety|December 24, 2002
Patients' understanding of risk associated with medication use: impact of European Commission guidelines and other risk scalesDianne C Berry, D K Raynor, Peter Knapp, et al.
Pageof 13